Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 25, Issue 5-6, 2001, Pages 893-902

  Al Omari, M M ^a   Abdelah, M K ^a   Badwan, A A ^a   Jaber, A M Y ^b  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS   (Saudi Arabia)

Author keywords

Diketopiperazine; Drug stability; Enalapril maleate; Enalaprilat; HPLC; Lubricating agents

Indexed keywords

BICARBONATE; BUFFER; ENALAPRIL MALEATE; ENALAPRILAT; HYDROGEN PEROXIDE; MAGNESIUM STEARATE; PIPERAZINEDIONE;

ARTICLE; DRUG DEGRADATION; DRUG STABILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; PH; PHOTOLYSIS; PRIORITY JOURNAL; TABLET FORMULATION; TEMPERATURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; ENALAPRIL; HYDROGEN-ION CONCENTRATION; KINETICS; LIGHT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0034997998     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(01)00399-5     Document Type: Article

References (10)

1. Shiromani P.K., Bavitz J.F. Drug Dev. Ind. Pharm. 12:1986;2467-2480.
2. Ip. And D.P., Brenner G.S. Florey K. Analytical Profiles of Drug Substances. 16:1987;207-243 Academic Press, London.
3. Gu L., Strickley R.G. Int. J. Pharm. 60:1990;99-107.
4. Gu L., Strickley R.G. Pharm. Res. 4:1987;392-397.
5. Gu L., Strickley R.G. Pharm. Res. 5:1988;765-771.
6. Strickley R.G., Visor G.C, Lin L., Gu L. Pharm. Res. 6:1989;971-975.
7. Gu L., Strickley R.G., Chi L., Chowhan Z.T. Pharm. Res. 7:1990;379-383.
8. Hanna S.A. Lieberman H.A., Lachman L., Schwartz J.B. Stability Kinetics, Pharmaceutical Dosage Forms: Tablets. 3:1990;477-478 Marcel Dekker, New York.
9. Desai D.S., Rubitski B.A., Bergum J.S., Varia S.A. Int. J. Pharm. 110:1994;254-265.
10. Enalapril Maleate Tablets Monograph under Assay, USP 23-NF 18, Supplement 8, (1998) pp.4204.